Yanan Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yanan Sun has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Aiai Chu
Department of Medicine (J.Z., S.R.N., Y.J., A.L.F., O.R., A.C., A.A.D.), Indiana University, Indianapolis
1 shared publication - Amit Arora
Department of Epidemiology and Biostatistics, Mel & Enid Zuckerman College of Public Health, University of Arizona (A.A.).
1 shared publication - Andrea L. Frump
Department of Medicine (J.Z., S.R.N., Y.J., A.L.F., O.R., A.C., A.A.D.), Indiana University, Indianapolis
1 shared publication - Ankit A. Desai
Department of Medicine, Indiana University, Indianapolis, Indiana
1 shared publication - Anna R. Hemnes
Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center , Nashville, TN
1 shared publication - Anna Walsworth
Division of Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, OH (K.L., A.W., W.C.N.).
1 shared publication
Latest Publications
- 18 May 2026
- Published by Wolters Kluwer Health in Circulation Research
Variation in SNX29 and Acute Vasodilator Response in Pulmonary Arterial Hypertension
BACKGROUND: Although pulmonary arterial hypertension (PAH) is a rare and fatal disease that is well-characterized, vasodilator-responsive PAH accounts for a minority of cases, with little mechanistic knowledge, but with dramatically improved survival. METHODS: By assembling national cohorts, we evaluated genetic influences on acute vasodilator drug response, a key determinant of the presence of vasodilator-responsive PAH. Differences between hemodynamics at rest and after a PAH-specific vasodilator were tested in a genome-wide association study. Validated loci were functionally tested in cell culture and in a hypoxic mouse model of pulmonary hypertension. RESULTS: Rs8057488 in the sorting nexin 29 ( SNX29 ) gene reached genome-wide significance in the discovery cohort ( P =4.00×10 −8 ) and was nominally replicated ( P =0.027). Consistent with its predicted function, SNX29 demonstrated an endosomal distribution in PA smooth muscle cells. Silencing SNX29 redistributed stromal interaction molecule proteins to the cell membrane and enhanced store-operated calcium entry. Over-expression of SNX29, in vivo, attenuated hypoxic vasoconstriction in isolated perfused murine lung models. CONCLUSIONS: The data cumulatively suggest SNX29 may contribute to vasodilation partly through reduced store-operated calcium entry and endosomal trafficking of store-operated calcium entry proteins, advancing our understanding of vasodilator-responsive PAH.
- 18 May 2026
- Published by Wolters Kluwer Health in Circulation Research
Variation in SNX29 and Acute Vasodilator Response in Pulmonary Arterial Hypertension
BACKGROUND: Although pulmonary arterial hypertension (PAH) is a rare and fatal disease that is well-characterized, vasodilator-responsive PAH accounts for a minority of cases, with little mechanistic knowledge, but with dramatically improved survival. METHODS: By assembling national cohorts, we evaluated genetic influences on acute vasodilator drug response, a key determinant of the presence of vasodilator-responsive PAH. Differences between hemodynamics at rest and after a PAH-specific vasodilator were tested in a genome-wide association study. Validated loci were functionally tested in cell culture and in a hypoxic mouse model of pulmonary hypertension. RESULTS: Rs8057488 in the sorting nexin 29 ( SNX29 ) gene reached genome-wide significance in the discovery cohort ( P =4.00×10 −8 ) and was nominally replicated ( P =0.027). Consistent with its predicted function, SNX29 demonstrated an endosomal distribution in PA smooth muscle cells. Silencing SNX29 redistributed stromal interaction molecule proteins to the cell membrane and enhanced store-operated calcium entry. Over-expression of SNX29, in vivo, attenuated hypoxic vasoconstriction in isolated perfused murine lung models. CONCLUSIONS: The data cumulatively suggest SNX29 may contribute to vasodilation partly through reduced store-operated calcium entry and endosomal trafficking of store-operated calcium entry proteins, advancing our understanding of vasodilator-responsive PAH.
- Open Access
- 24 February 2025
- Published by Elsevier in Extracellular Vesicle
- Vol. 5
A method for isolating small extracellular vesicles from parenchymal tissues
- 24 February 2025
- Published by Elsevier in Extracellular Vesicle
- Vol. 5
Open AccessA method for isolating small extracellular vesicles from parenchymal tissues